ClinicalTrials.Veeva

Menu

The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark. (DOSCA-2)

University of Aarhus logo

University of Aarhus

Status

Invitation-only

Conditions

Squamous Cell Carcinoma of the Skin
Basal Cell Carcinoma of Skin
Non-Melanoma Skin Cancer (NMSC)

Treatments

Other: Follow-up visit at least two years after treatment

Study type

Observational

Funder types

Other

Identifiers

NCT07347392
DOSCA-2-AUH

Details and patient eligibility

About

The goal of this observational study is to learn about the long-term effects of radiotherapy for people who were treated for non-melanoma skin cancer (NMSC) in the head and neck area. The study focuses on adults who finished radiotherapy at least two years ago.

The main questions we aim to answer are:

How satisfied are participants with the cosmetic result of their treatment?

What skin changes do healthcare professionals observe at the treated area?

How many participants have experienced a recurrence or developed a new skin cancer, since treatment?

Participants will be invited to:

Attend one extra hospital visit at least two years after they finished radiotherapy

Answer a short questionnaire about their cosmetic satisfaction

Have their skin examined, including photos and dermatoscopy

The results may help improve future treatment guidelines for people with non-melanoma skin cancer.professional, and any local recurrences will be identified through national health registries.

This nationwide study (DOSCA-2) will provide real-world data to help guide future treatment recommendations for NMSC.

Enrollment

2,900 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 years or older
  • Received primary radiotherapy for malignant non-melanoma skin cancer (basal cell carcinoma or cutaneous squamous cell carcinoma) of the head and neck region between 2020 and 2024
  • Able to understand and communicate in written and spoken Danish or English

Exclusion criteria

  • Individuals who are incapable of giving informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems